Engineers Gate Manager’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding CBIO
OM
Engineers Gate Manager's CBIO Position: Q3 2026 in Review
Engineers Gate Manager opened a new position in Crescent Biopharma (CBIO) in Q3 2026: 28,640 shares worth $418K. The stake represents 0.01% of the portfolio and ranks #1637 among its holdings.
104 funds tracked by Wall St. Rank hold CBIO as of Q3 2026.
- Engineers Gate Manager held 28,640 shares of Crescent Biopharma worth $418K as of Q3 2026.
- Crescent Biopharma was a new Engineers Gate Manager position in Q3 2026.
- Crescent Biopharma made up 0.01% of Engineers Gate Manager's portfolio in Q3 2026, its #1637 holding.
- 104 funds tracked by Wall St. Rank held Crescent Biopharma as of Q3 2026.
Based on Engineers Gate Manager's 13F filing for Q3 2026, filed 16 Nov 2026.